Category Press Releases

Cancer,Pearsanta

Pearsanta Acquires Adductomics Tech for Early Cancer Detection

Pearsanta Acquires Adductomics Tech for Cancer Risk Monitoring Aditxt, Inc. (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, has announced that its subsidiary, Pearsanta, Inc. (“Pearsanta”), has completed the acquisition of key patents related to adductomics-based…

Read MorePearsanta Acquires Adductomics Tech for Early Cancer Detection
Poxel

Poxel Reports Positive Preclinical Results for PXL065 in HCM

Poxel Reports Positive Preclinical Results for PXL065 in HCM POXEL SA, a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for chronic and serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, has announced positive…

Read MorePoxel Reports Positive Preclinical Results for PXL065 in HCM
Drug Resistance

Kairos Pharma Publishes Breakthrough on Overcoming Drug Resistance in NSCLC

Kairos Pharma Publishes Breakthrough on Overcoming Drug Resistance in NSCLC Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, has announced a significant breakthrough in addressing drug resistance to EGFR-targeted therapies for non-small cell lung cancer (NSCLC). A recent peer-reviewed publication in…

Read MoreKairos Pharma Publishes Breakthrough on Overcoming Drug Resistance in NSCLC